// App-Quantinova.ai

: Comparison of plasma amyloid, tau, and astrocyte biomarkers to identify AD pathophysiology

Researchers

Presenter

  • Pamela C.L. Ferreira

Principal Investigators

  • João Pedro Ferrari-Souza

  • Bruna Bellaver

  • Wagner S. Brum

  • Douglas Teixeira Leffa

  • Joseph Therriault

  • Andréa Lessa Benedet

  • Stijn Servaes

  • Firoza Z Lussier

  • Mira Chamoun

  • Jenna Stevenson

  • Nesrine Rahmouni

  • Dana L Tudorascu

  • William E Klunk

  • Victor L Villemagne

  • Ann D Cohen

  • Eduardo R. Zimmer

  • Nicholas J. Ashton

  • Henrik Zetterberg

  • Kaj Blennow

  • Thomas K Karikari

  • Pedro Rosa-Neto

  • Tharick A Pascoal

Medical Centers

  • Translational Neuroimaging Laboratory

  • Translational Neuroimaging Laboratory, The McGill University Research Centre for Studies in Aging

  • Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Sweden

  • Institute of Psychiatry, Psychology & Neuroscience, King's College London

  • University of Gothenburg,

  • Universidade Federal do Rio Grande do Norte, Sao Paulo, Brazil.

  • University of Pittsburgh, PA

  • Hospital de Clinicas de Porto Alegre, Brazil

  • The University of Pittsburgh

  • McGill University,

  • Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London

  • Departments of Psychiatry and Neurology, University of Pittsburgh School of Medicine

  • Hong Kong Center for Neurodegenerative Diseases

  • UK Dementia Research Institute

  • Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg

Locations

  • United States

  • Brazil

  • United Kingdom

  • Hong Kong

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Amyloid beta 42

  • Glial fibrillary acidic protein

  • Neurofilament-light chain

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A